Aerobic Capacity and Body Composition in Colon Cancer Patients
Changes in Aerobic Capacity and Body Composition in Colon Cancer Patients Receiving Chemotherapy
1 other identifier
observational
40
1 country
1
Brief Summary
Recent studies have shown that survival after a colorectal cancer diagnosis may be affected by a person's activity level and body size. This research says that for colorectal cancer patients, the less active and more obese they are, the more likely they are to have a cancer recurrence or die from their cancer. Chemotherapy has been shown to reduce activity levels, fitness, and body size in some cancer patients. However, it is not known how chemotherapy specific for colon cancer patients affects their activity levels, fitness, and body size. The main goal of our study will be to look at how chemotherapy treatments affect the fitness, activity levels, and body size in colon cancer patients. In order to do this, we will measure these variables before chemotherapy treatments, and at 1 and 6 months following the end of treatment. Our results will show how chemotherapy affects fitness, activity levels, and body size in colon cancer patients and provide data to help in designing an exercise intervention specifically for colon cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2007
CompletedFirst Posted
Study publicly available on registry
May 8, 2007
CompletedStudy Start
First participant enrolled
October 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedFebruary 26, 2016
April 1, 2012
2 years
May 7, 2007
February 24, 2016
Conditions
Keywords
Eligibility Criteria
community sample
You may qualify if:
- histologically confirmed colon cancer (Stage III and those Stage II patients deemed high-risk
- approval of the treating oncologist
- scheduled to received chemotherapy
- able to understand and provide written informed consent in English
- + years of age
- no uncontrolled co-morbidities (including hypertension, cardiac illness, psychiatric condition, etc.)
- negative ECG as assessed during maximal graded exercise test
You may not qualify if:
- metastatic or recurrent colon cancer patients
- pregnancy
- any uncontrolled medical condition that would be a contraindication to exercise (assessed by treating oncologist)
- unwilling to attend, travel to or participate in the assessments at all 3 time points
- In addition, 10 patients meeting all of the eligibility criteria who are not scheduled to receive chemotherapy will also be recruited to the study to serve as "surgery only" controls.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kerry Courneya, PhD
University of Alberta
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2007
First Posted
May 8, 2007
Study Start
October 1, 2007
Primary Completion
October 1, 2009
Study Completion
October 1, 2009
Last Updated
February 26, 2016
Record last verified: 2012-04